AMOXAPINE Drug Patent Profile
✉ Email this page to a colleague
When do Amoxapine patents expire, and when can generic versions of Amoxapine launch?
Amoxapine is a drug marketed by Chartwell Rx, Watson Labs, and Watson Pharms Teva. and is included in six NDAs.
The generic ingredient in AMOXAPINE is amoxapine. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxapine
A generic version of AMOXAPINE was approved as amoxapine by WATSON LABS on August 28th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMOXAPINE?
- What are the global sales for AMOXAPINE?
- What is Average Wholesale Price for AMOXAPINE?
Summary for AMOXAPINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,662 |
| Drug Prices: | Drug price information for AMOXAPINE |
| DailyMed Link: | AMOXAPINE at DailyMed |
Recent Clinical Trials for AMOXAPINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Alexza Pharmaceuticals, Inc. | Phase 1 |
Pharmacology for AMOXAPINE
| Drug Class | Tricyclic Antidepressant |
Medical Subject Heading (MeSH) Categories for AMOXAPINE
Anatomical Therapeutic Chemical (ATC) Classes for AMOXAPINE
US Patents and Regulatory Information for AMOXAPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | AMOXAPINE | amoxapine | TABLET;ORAL | 072879-002 | Jun 28, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072691-004 | Aug 28, 1992 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | AMOXAPINE | amoxapine | TABLET;ORAL | 072879-001 | Jun 28, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072421-001 | May 11, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072691-001 | Aug 28, 1992 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
